Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2022 Update

Summary

Nexstim Plc (Nexstim), a medical technology company that develops, manufactures and commercializes non-invasive brain stimulation technologies and devices to treat patients suffering from depressive disorders and chronic pain. The company provides Navigated Brain Therapy (NBT) system for the treatment of major depression disorder (MDD) and chronic neuropathic pain and Navigated Brain Stimulation (NBS) system for pre-surgical diagnostics. The company also develops products based on its proprietary SmartFocus TMS technology. Nexstim offers its products primarily to leading hospitals and universities through direct sales and distributors in the US, Europe, and Asia. The company has operations in Finland, Germany, and the US. Nexstim is headquartered in Helsinki, Finland

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Nexstim Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Nexstim Plc Company Overview
Nexstim Plc Company Snapshot
Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview
Nexstim Plc – Pipeline Analysis Overview
Business Description
Nexstim Plc - Key Facts
Nexstim Plc - Major Products and Services
Nexstim Plc Pipeline Products by Development Stage
Nexstim Plc Ongoing Clinical Trials by Trial Status
Nexstim Plc Pipeline Products Overview
Navigated Brain Therapy System - Chronic Neuropathic Pain
Navigated Brain Therapy System - Chronic Neuropathic Pain Product Overview
Navigated Brain Therapy System - Chronic Neuropathic Pain Clinical Trial
Navigated Brain Therapy System - Chronic Spinal Cord Injury
Navigated Brain Therapy System - Chronic Spinal Cord Injury Product Overview
Navigated Brain Therapy System - Major Depressive Disorder
Navigated Brain Therapy System - Major Depressive Disorder Product Overview
Navigated Brain Therapy System - Major Depressive Disorder Clinical Trial
Navigated Brain Therapy System - Tinnitus
Navigated Brain Therapy System - Tinnitus Product Overview
Wireless EMG Integrated NBS System
Wireless EMG Integrated NBS System Product Overview
Nexstim Plc - Key Competitors
Nexstim Plc - Key Employees
Nexstim Plc - Key Employee Biographies
Nexstim Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Nexstim Plc, Recent Developments
Dec 17, 2022: Nexstim announces Changes in the management team
Aug 12, 2022: Nexstim Announces Half-year Report January 1 - June 30, 2022 (Unaudited)
May 30, 2022: Nexstim to Present at Redeye Growth Day 2022
Mar 31, 2022: Nexstim Plc’s resolutions of the Annual General Meeting of Shareholders
May 11, 2021: Nexstim resolutions of the Annual General Meeting of Shareholders
Apr 20, 2021: Correction to the Invitation to the Annual General Meeting of Nexstim
Mar 31, 2021: Nexstim reschedules its Annual General Meeting to 11 May 2021
Mar 01, 2021: Nexstim Resolutions of the Extraordinary General Meeting
Feb 19, 2021: Notice of Nexstim Plc 2020 Full Year Results
Nov 18, 2020: Nexstim signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Nexstim Plc Pipeline Products by Equipment Type
Table 3: Nexstim Plc Pipeline Products by Indication
Table 4: Nexstim Plc, Key Facts
Table 5: Nexstim Plc, Major Products and Services
Table 6: Nexstim Plc Number of Pipeline Products by Development Stage
Table 7: Nexstim Plc Pipeline Products Summary by Development Stage
Table 8: Nexstim Plc Ongoing Clinical Trials by Trial Status
Table 9: Nexstim Plc Ongoing Clinical Trials Summary
Table 10: Navigated Brain Therapy System - Chronic Neuropathic Pain - Product Status
Table 11: Navigated Brain Therapy System - Chronic Neuropathic Pain - Product Description
Table 12: Navigated Brain Therapy System - Chronic Neuropathic Pain - A Pilot Study of Nexstim NBT System in the Treatment of Patients with Therapy Resistant, Chronic Neuropathic Pain
Table 13: Navigated Brain Therapy System - Chronic Spinal Cord Injury - Product Status
Table 14: Navigated Brain Therapy System - Chronic Spinal Cord Injury - Product Description
Table 15: Navigated Brain Therapy System - Major Depressive Disorder - Product Status
Table 16: Navigated Brain Therapy System - Major Depressive Disorder - Product Description
Table 17: Navigated Brain Therapy System - Major Depressive Disorder - Use of Nexstim SNBT System in Its Intended Use
Table 18: Navigated Brain Therapy System - Tinnitus - Product Status
Table 19: Navigated Brain Therapy System - Tinnitus - Product Description
Table 20: Wireless EMG Integrated NBS System - Product Status
Table 21: Wireless EMG Integrated NBS System - Product Description
Table 22: Nexstim Plc, Key Employees
Table 23: Nexstim Plc, Key Employee Biographies
Table 24: Nexstim Plc, Subsidiaries
Table 25: Glossary
List of Figures
Figure 1: Nexstim Plc Pipeline Products by Equipment Type
Figure 2: Nexstim Plc Pipeline Products by Development Stage
Figure 3: Nexstim Plc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings